Dermatology department - faculty of medicine- Cairo University
Cairo, Egypt
NCT Number: NCT01545869
Freckles are clusters of melanin in the superficial epidermis. They affect mostly face and sun exposed areas, and appear as flat brown or red macules that fade in winter, usually in a fair complexion patient, but may be present in other skin types.
The gold standard in the industry for non-surgical facial rejuvenation, removal of wrinkles, pigmentation, and general sun damage has been the carbon dioxide (CO2) laser since the mid 1990s. The traditional CO2 laser was very effective, however it fell out of favor because it required general anesthesia. It also had a prolonged recovery time. Over the last several years, advances in technology known as fractional resurfacing has made the CO2 laser popular again: Fractional CO2 laser treatment is one of the newest laser rejuvenation technology. It proved successful in treatment of melasma, one of the pigmented dermatoses. To the best of our knowledge, based on a thorough search of literature, no clinical studies assessing fractional CO2 laser in treatment of freckles could be retrieved.
Looking for future studies?
Notify Me10 year and older
All sexes
Interventional
Not applicable
Cairo, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SmartXide fractional carbon dioxide laser (DEKA, Florence, Italy). Parameters adjusted for: Power 20 watts, spacing 200 µsec, dwell time 300 µm, stacks 1.
Other names: Ablative fractional laser resurfacing
Time frame: One month
reduction of freckles number and color density more than 50% in comparison to pre-treatment digital photos
Time frame: three months
Absence of irreversible changes in color and texture of the facial skin, that can cause patient dissatisfaction
Cairo University
Other
Efficacy and Safety of Fractional Carbon Dioxide Laser for Treatment of Facial Freckles
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07352631
Freckles, Hyperpigmentation
Bengbu, Anhui, China
View Trial DetailsNCT07727954
Hyperpigmentation, Melanosis
Tijuana, Estado de Baja California, Mexico
View Trial DetailsNCT07722351
Hyperpigmentation, Melanosis
Sosnowiec, Poland
View Trial DetailsNCT07676994
Hyperpigmentation, Melanosis
Lahore, Pakistan
View Trial Details